×
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
LON:OBD

Oxford BioDynamics Share Forecast, Price & News

GBX 13.85
+0.35 (+2.59%)
(As of 07/1/2022 12:00 AM ET)
Add
Compare
Today's Range
13.50
14.45
50-Day Range
12.32
20.96
52-Week Range
11.25
62.80
Volume
96,577 shs
Average Volume
317,417 shs
Market Capitalization
£13.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Oxford BioDynamics MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.10mentions of Oxford BioDynamics in the last 14 days
Based on 4 Articles This Week
Insider Trading
Acquiring Shares
£965 K Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

0.51 out of 5 stars

30 days | 90 days | 365 days | Advanced Chart

Receive OBD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oxford BioDynamics and its competitors with MarketBeat's FREE daily newsletter.

Oxford BioDynamics logo

About Oxford BioDynamics (LON:OBD) Stock

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use in the pharmaceutical and biotechnology industry primarily in the United States and internationally. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures for use in medical testing kits, disease prediction, diagnosis, and treatment. Its products include EpiSwitch CiRT (Checkpoint Inhibitor Response Test), a validated prognostic test for predicting response to checkpoint inhibitor immunotherapy; EpiSwitch CST (Covid Severity Test), an advanced blood test for the prediction of COVID-19 severity in adults; and EpiSwitch Explorer Array Kit for high-resolution 3D genome profiling and biomarker discovery. Oxford BioDynamics Plc was incorporated in 2007 and is headquartered in Oxford, the United Kingdom.

OBD Stock News Headlines

Oxford BioDynamics (LON:OBD) Hits New 52-Week Low at $16.00
Oxford BioDynamics Plc (OBD.L)
Oxford Biodyn Share News (OBD)
Oxford BioDynamics PLC
Oxford Biodyn Regulatory News
Oxford BioDynamics losses widen in first half
See More Headlines

Industry, Sector and Symbol

Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
39
Year Founded
N/A

Company Calendar

Last Earnings
6/16/2020
Today
7/03/2022

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£176 thousand
Cash Flow
GBX 5.28 per share
Book Value
GBX 6.60 per share

Miscellaneous

Free Float
N/A
Market Cap
£13.90 million
Optionable
Not Optionable
Beta
N/A














Oxford BioDynamics Frequently Asked Questions

How has Oxford BioDynamics' stock performed in 2022?

Oxford BioDynamics' stock was trading at GBX 38.25 at the start of the year. Since then, OBD shares have decreased by 63.8% and is now trading at GBX 13.85.
View the best growth stocks for 2022 here
.

How were Oxford BioDynamics' earnings last quarter?

Oxford BioDynamics Plc (LON:OBD) announced its quarterly earnings data on Tuesday, June, 16th. The biotechnology company reported ($2.20) earnings per share for the quarter.
View Oxford BioDynamics' earnings history
.

Who are Oxford BioDynamics' key executives?

Oxford BioDynamics' management team includes the following people:
  • Dr. Jon Anthony Joseph Burrows B.Sc., M.Sc., Ph.D., CEO & Director (Age 59, Pay $463k)
  • Mr. Paul Leslie Stockdale F.C.A., M.A., CFO & Director (Age 47, Pay $202k)
  • Dr. Alexandre Akoulitchev Ma (Oxon), Ph.D., Chief Scientific Officer & Director (Age 60, Pay $236k)
  • Mr. Thomas G. Guiel B.A., Chief Operating Officer
  • Dr. Jayne Green B.Sc., Ph.D., Director of Operations
  • Dr. Aroul Ramadass M.Sc., Ph.D., Ph.D.(CANTAB), PDF (OXON), FCPS, FRA, Chief Technology Officer
  • Dr. Ewan Hunter B.Sc., Ph.D., BSC, Ph.D., (KCL), Group CDO
  • Mr. Bipin Patel, Head of RA/QA
  • T. Demain, Company Sec.
  • Dr. Steven Tucker M.D., FACP, Group Clinical Director

What other stocks do shareholders of Oxford BioDynamics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Oxford BioDynamics investors own include Oxford Biomedica (OXB), Frontline (FRO), Fate Therapeutics (FATE), Cargojet (CJT), China Unicom (Hong Kong) (CHU), Casey's General Stores (CASY), Buckle (BKE), Biffa (BIFF), AXT (AXTI) and Grupo Aval Acciones y Valores (AVAL).

What is Oxford BioDynamics' stock symbol?

Oxford BioDynamics trades on the London Stock Exchange (LON) under the ticker symbol "OBD."

How do I buy shares of Oxford BioDynamics?

Shares of OBD and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Oxford BioDynamics' stock price today?

One share of OBD stock can currently be purchased for approximately GBX 13.85.

How much money does Oxford BioDynamics make?

Oxford BioDynamics (LON:OBD) has a market capitalization of £13.90 million and generates £176 thousand in revenue each year.

How many employees does Oxford BioDynamics have?

Oxford BioDynamics employs 39 workers across the globe.

How can I contact Oxford BioDynamics?

Oxford BioDynamics' mailing address is 26 Beaumont Street, OXFORD, OX1 2NP, United Kingdom. The official website for Oxford BioDynamics is www.oxfordbiodynamics.com. The biotechnology company can be reached via phone at +44-1865-518910.

This page (LON:OBD) was last updated on 7/3/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.